Role of total tumour load of sentinel lymph node on survival in early breast cancer patients.

[1]  A. Sapino,et al.  Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method , 2015, Journal of experimental & clinical cancer research : CR.

[2]  Y. Tamaki.  Recent advances in sentinel node biopsy for breast cancer One-step nucleic acid amplification assay ( OSNA ) for sentinel lymph node biopsy , 2012 .

[3]  Y. Tamaki,et al.  One-step nucleic acid amplification assay for intraoperative prediction of non-sentinel lymph node metastasis in breast cancer patients with sentinel lymph node metastasis. , 2014, Breast.

[4]  V. Peg,et al.  Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients , 2014, Breast Cancer Research and Treatment.

[5]  Sean Ferree,et al.  Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens , 2014, BMC Cancer.

[6]  C. Perou,et al.  Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  V. Peg,et al.  Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8]  A. Petit,et al.  Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients , 2013, Breast Cancer Research and Treatment.

[9]  D. Ramírez,et al.  Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer , 2013, Clinical and Translational Oncology.

[10]  A. Tanimoto,et al.  Whole sentinel lymph node analysis by a molecular assay predicts axillary node status in breast cancer , 2012, British Journal of Cancer.

[11]  H. Kuerer,et al.  American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns , 2012, Annals of Surgical Oncology.

[12]  N. Demartines,et al.  Molecular Investigation of Lymph Nodes in Colon Cancer Patients Using One-Step Nucleic Acid Amplification (OSNA) , 2012, Cancer.

[13]  K. Matsuo,et al.  Intraoperative Molecular Assessment for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma Using One-Step Nucleic Acid Amplification (OSNA) Assay , 2012, Annals of Surgical Oncology.

[14]  G. Chatellier,et al.  Diagnostic performance of one‐step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients , 2012, International journal of cancer.

[15]  A. Naik,et al.  Impact of American College of Surgeons Oncology Group Z0011 and National Surgical Adjuvant Breast and Bowel Project B-32 trial results on surgeon practice in the Pacific Northwest. , 2012, American Journal of Surgery.

[16]  P. A. Futreal,et al.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.

[17]  A. Sapino,et al.  Reliability of Whole Sentinel Lymph Node Analysis by One-Step Nucleic Acid Amplification for Intraoperative Diagnosis of Breast Cancer Metastases , 2012, Annals of surgery.

[18]  Gábor Cserni,et al.  Intraoperative analysis of sentinel lymph nodes in breast cancer by one-step nucleic acid amplification , 2011, Journal of Clinical Pathology.

[19]  F. Akiyama,et al.  Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer , 2011, Cancer.

[20]  F. Akiyama,et al.  Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method , 2011, British Journal of Cancer.

[21]  R. Greil,et al.  A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors , 2011, Clinical Cancer Research.

[22]  X. Matías-Guiu,et al.  Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study , 2011, Histopathology.

[23]  Bernet Vegué Laia,et al.  Molecular Diagnosis of Sentinel Lymph Nodes for Breast Cancer: One Step Ahead for Standardization , 2011, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[24]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[25]  Donald L. Weaver,et al.  Effect of occult metastases on survival in node-negative breast cancer. , 2011, The New England journal of medicine.

[26]  A. Luini,et al.  Sentinel Lymph Node Biopsy in Breast Cancer: Ten-Year Results of a Randomized Controlled Study , 2010, Annals of surgery.

[27]  D. Weaver,et al.  Metastasis Detection in Sentinel Lymph Nodes: Comparison of a Limited Widely Spaced (NSABP Protocol B-32) and a Comprehensive Narrowly Spaced Paraffin Block Sectioning Strategy , 2009, The American journal of surgical pathology.

[28]  W. Jonat,et al.  One-step nucleic acid amplification—a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group , 2009, Virchows Archiv.

[29]  H. Tsuda,et al.  Molecular Detection of Lymph Node Metastases in Breast Cancer Patients: Results of a Multicenter Trial Using the One-Step Nucleic Acid Amplification Assay , 2009, Clinical Cancer Research.

[30]  P. V. van Diest,et al.  Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer , 2008, International journal of cancer.

[31]  H. Tsuda,et al.  One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients , 2007, Clinical Cancer Research.

[32]  I. Ellis,et al.  High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma , 2007, The American journal of surgical pathology.

[33]  Umberto Veronesi,et al.  Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. , 2006, The Lancet. Oncology.

[34]  L. V. van't Veer,et al.  Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer. , 2006, Journal of the National Cancer Institute.

[35]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[36]  J. Peterse,et al.  Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology , 2004, Journal of Clinical Pathology.

[37]  Umberto Veronesi,et al.  A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. , 2003, The New England journal of medicine.

[38]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[39]  V. Quillien,et al.  Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA) , 2011, Breast Cancer Research and Treatment.

[40]  Donald E. Henson,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .